Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp
published in: The Lancet
date of publication: 2016-06-13
language: English
main subject: phase III clinical trial, cytarabine, mantle cell lymphoma
Cites articles 26
Date
Title
Article - wd:Q40696072